Overview
Amplicon is a biotechnology company that specializes in developing diagnostic tests based on real-time PCR technology, utilizing data from DNA sequences. They provide precise and reliable diagnostic tests for infectious and genetic diseases in both humans and animals, and they also design, optimize, and validate molecular diagnostic assays. Additionally, they conduct a range of highly specialized molecular research studies.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-05-01. Active
34 1140 2004 0000 3102 7510 2857
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
13 public aid cases recorded, with a total value of $92,844.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 25, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $122$122 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jan 16, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $296$296 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 1, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $243$243 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-10-01 | Opracowanie i walidacja panelowego testu diagnostycznego do oceny ryzyka zapadnięcia na chorobę otępienną i wdrożenia spersonalizowanej metody terapii farmakologicznej oraz algorytmu do interpretacji wyników | $174.9K$174,913 | Regionalny Program Operacyjny Województwa Dolnośląskiego 2014-2020 |
Tenders
6 tenders recorded as contractor, with a total value of $72,894.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 8, 2025 | Testy diagnostyczne II | $968$968 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Bydgoszczy | |
| Jul 10, 2024 | Testy diagnostyczne III | $2,234$2,234 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Bydgoszczy | |
| Mar 13, 2024 | Testy diagnostyczne I | $10,663$10,663 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Bydgoszczy |
Authorized Representatives
Manner of representation
In the case of a multi-member management board: the members of the management board act independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Janusz Krzysztof Piechota (49) | 10 | $2,701.24 | 50% |
Małgorzata Piskozub (44) | 10 | $2,701.24 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Janusz Krzysztof Piechota (49)  | Shareholder of a limited liability company, 10000.0 PLN |
Małgorzata Piskozub (44) | Shareholder of a limited liability company, 10000.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-06-05 | PKD change (Added: 21.20.Z, 86.90.E) | |
| 2019-03-22 | Address change (Duńska 9, 54-427, Wrocław → Ul. Klecińska 125, 54-413, Wrocław) | |
| 2014-03-14 | Entered in the register |
FAQ
Last updated: 2026-07-16